QPHI
research

Apply for research

research

Register For Participation

Clinical Research in Precision Medicine, Rare Diseases, and Pharmacogenomics

 
Organizers:  QPHI’s Tanawwo Program, in partnership with the Principles and Practice of Clinical Research (PPCR) Program (a program from the ECE Department, Harvard T.H. Chan School of Public Health) and Qatar University
     
Qatar Precision Health Institute (QPHI) through its Tanawwo program, partnered with the Principles and Practice of Clinical Research (PPCR) Program (a program from the ECE Department, Harvard T.H. Chan School of Public Health) and Qatar University, to organize a 4-day workshop on Clinical Research in Precision Medicine, Rare Diseases, and Pharmacogenomics. This workshop delivered a unique, multidisciplinary training experience at the intersection of genomics, clinical research, and innovation. 

Participants gained in-depth knowledge of clinical research methodologies and their application to precision medicine, rare diseases, and pharmacogenomics. The program integrated classical trial design with emerging innovations in AI, big data, and multi-omics, offering both theoretical foundations and practical, hands-on exercises. Through lectures, panel discussions, and facilitated workshops, attendees explored key themes including research ethics, regulatory frameworks, adaptive trial designs, patient registries, pharmacogenomics applications, and AI-driven approaches to clinical trials. In addition, participants who are interested were invited to apply to the 2026 PPCR program offered by Harvard TH Chan School of Public Health to continue their training in clinical Research Designed for clinicians, researchers, policymakers, and early-career scientists, the workshop equipped participants with practical skills, fostered collaboration, and contributed to Qatar’s growing precision health ecosystem—while offering the opportunity to learn directly from world-renowned experts at Harvard, QPHI, and QU.  
About The Program
Who Attended?
This workshop was designed for:
  • Clinicians and healthcare professionals involved in research and patient care
  • Clinical researchers and trial coordinators
  • Geneticists, molecular biologists, and bioinformaticians
  • Pharmacologists and pharmacogenomics specialists
  • Public health professionals and policymakers
  • Graduate students and early-career researchers interested in precision medicine
Key Benefits of Attending
  • Learn from Harvard, WHO experts, and Qatar faculty and experts in clinical research and regulation.
  • Gain practical, hands-on experience through facilitated workshops on protocol design, consent material development, and omics-driven trials
  • Understand cutting-edge innovations in trial methodology, ethics, and precision medicine applications.
  • Participate in interactive panels and real-world case discussions involving both HIC and LMIC contexts.
  • Build meaningful connections with academic, regulatory, and clinical experts from Qatar and beyond.
Learning Outcomes
By the end of the workshop, participants:
  • Built a strong foundation in clinical research methodologies and trial design
  • Understand global best practices in ethics and governance, including WHO frameworks
  • Acquire the ability to design and evaluate studies in precision medicine, rare diseases, and pharmacogenomics
  • Gain insights into AI, big data, and omics-driven approaches for clinical research
  • Be able to translate concepts into practice through structured, facilitated exercises. 
Workshop Details